Vorinostat Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01169532Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma